ACUTE ISCHEMIC STROKE
Clinical trials for ACUTE ISCHEMIC STROKE explained in plain language.
Never miss a new study
Get alerted when new ACUTE ISCHEMIC STROKE trials appear
Sign up with your email to follow new studies for ACUTE ISCHEMIC STROKE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor stem cells tested to repair stroke damage
Disease control NO_LONGER_AVAILABLEThis study tested whether a one-time intravenous infusion of donor stem cells (mesenchymal stem cells) could help people who recently had a severe ischemic stroke. Participants were adults aged 18 to 80 who had a stroke within the past 9 days. The goal was to see if the cells cou…
Matched conditions: ACUTE ISCHEMIC STROKE
Sponsor: University of Miami • Aim: Disease control
Last updated May 18, 2026 15:29 UTC
-
Stroke device study pulled before it even started
Disease control TerminatedThis study was designed to test a new device called the CEREGLIDE 92 catheter for removing blood clots in people having a severe stroke. It aimed to see if the device could restore blood flow on the first try. However, the study was withdrawn before any volunteers were enrolled, …
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: NA • Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc. • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Brain-Cooling magnesium after clot removal: a new hope for stroke recovery?
Disease control ENROLLING_BY_INVITATIONThis study tests if infusing a cooled magnesium solution directly into the brain's arteries after removing a clot can improve recovery for people with severe stroke. About 42 adults aged 18-80 with a large vessel blockage in the front part of the brain will be enrolled. The goal …
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: PHASE1, PHASE2 • Sponsor: Capital Medical University • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
New stent shows promise for stroke patients
Disease control OngoingThis study tests a special stent (CGuard Prime) placed in the neck artery to treat acute ischemic stroke. It involves 15 adults with severe stroke symptoms and blocked arteries. The goal is to see if the stent is safe and helps patients recover better by 90 days.
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: NA • Sponsor: Jacobs institute • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New stroke drug shows promise in major trial
Disease control OngoingThis study tests an experimental drug called redasemtide in 680 adults who have had a stroke caused by a blocked blood vessel. Participants receive either the drug or a placebo within 25 hours of their stroke. The goal is to see if the drug helps people recover better and have le…
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Stroke device study pulled before it even started
Disease control TerminatedThis study planned to test a device called the SOFIA Flow 88 Aspiration Catheter for removing blood clots in people having a severe stroke. The goal was to see if it could safely restore blood flow to the brain. However, the study was withdrawn before enrolling any participants, …
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: NA • Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Could a common steroid boost stroke survival? major trial underway.
Disease control OngoingThis study tests whether giving the steroid methylprednisolone along with standard clot-removal treatment can reduce deaths in people who have had a major stroke. About 928 adults with large strokes will be randomly assigned to receive either the steroid or a placebo. The main go…
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: PHASE3 • Sponsor: Wan-Jin Chen • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New hope for mild stroke patients: clot removal may boost recovery
Disease control OngoingThis study compares a minimally invasive procedure (endovascular treatment) to standard care for 300 adults aged 18-80 who have had a mild stroke caused by a blocked large artery in the front part of the brain. Participants must be treated within 24 hours of symptoms starting. Th…
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: NA • Sponsor: Zhangzhou Municipal Hospital • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Stroke drug study pulled before it even started
Disease control TerminatedThis study aimed to see if adding the antibiotic minocycline to standard stroke treatment could help people recover better after a severe stroke caused by a blocked large artery. The plan was to give some patients minocycline for 21 days and others a placebo, then compare their d…
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: PHASE2 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Could a targeted clot-buster boost stroke recovery?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether giving the clot-busting drug tenecteplase directly into the brain artery after mechanical clot removal is safe and feasible for people with acute ischemic stroke. About 40 adults who had a large-vessel blockage stroke within the last 4.5 to 24 hours will …
Matched conditions: ACUTE ISCHEMIC STROKE
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 18, 2026 12:11 UTC
-
New imaging study could sharpen stroke diagnosis
Knowledge-focused OngoingThis study looks at 20 adults who recently had a stroke to compare two types of brain scans: CT and PET. The goal is to see how well PET scans measure blood flow and brain cell activity compared to standard CT scans. Participants will get both scans within a week of their stroke,…
Matched conditions: ACUTE ISCHEMIC STROKE
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC